Uveitis
📧 Sign up to get email alerts when something new happens for Uveitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing [NA]
Clinical trial results investigating ocular pathogens and transcriptome using comprehensive sequencing in uveitis and infectious disease.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Intestinal Bacteria and Ocular Inflammatory Disease
A completed clinical trial investigating the relationship between intestinal bacteria and uveitis (ocular inflammatory disease) conducted by…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant
This clinical trial update summarizes imaging findings in uveitis patients treated with the fluocinolone acetonide intravitreal implant (ILU…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital
The study evaluated switching patients from original infliximab to its biosimilar in daily practice at Cochin Hospital, across rheumatoid ar…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study) [Phase 2]
A Phase 2 study evaluating adrenocorticotropic hormone (ACTH) using ACTHAR for uveitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis [Phase 2]
This update reports the completion of a Phase 2 randomized trial comparing adalimumab, anakinra, and tocilizumab for non-infectious refracto…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating adalimumab for uveitis in juvenile idiopathic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis [NA]
The trial evaluating a standardized strategy for etiologic diagnosis of uveitis has completed. The document does not report treatment result…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Characteristics of Ankylosing Spondylitis Associated Uveitis
A completed clinical trial update describing the characteristics of uveitis in patients with ankylosing spondylitis.
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Adalimumab vs. Conventional Immunosuppression for Uveitis Trial [Phase 3]
Phase 3 trial comparing adalimumab to conventional immunosuppression for uveitis has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Adalimumab in JIA-associated Uveitis Stopping Trial [Phase 4]
Phase 4 trial of adalimumab for Juvenile Idiopathic Arthritis-associated uveitis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis [Phase 2]
ACELYRIN's Phase 2b pivotal study of Izokibep for non-infectious uveitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRA [Phase 2]
Phase 2 study assessing the effectiveness of anti-tuberculosis therapy in IGRA-positive uveitis, including tuberculous uveitis.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV) [Phase 4]
Phase 4 trial evaluating safety and clinical efficacy of QLETLI in non-infectious uveitis is active but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of an injectable fluocinolone acetonide intravitreal insert for uveitis has been terminat…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Vitamin and Unsaturated Fatty Acid Supplements in Healthy and Uveitis Human Subjects [NA]
A completed clinical trial from Tianjin Medical University evaluated vitamin and unsaturated fatty acid supplementation in healthy individua…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
This trial studied the vitreous proteome and inflammatory mediators in ocular inflammatory disease, including uveitis and vasculitis, and ha…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Six-months Versus Nine-months ATT for Ocular TB [Phase 4]
Completed Phase 4 trial comparing six-month versus nine-month anti-tuberculosis therapy durations for ocular tuberculosis, evaluating condit…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Nailfold Capillaroscopic Assessment in Pediatric Uveitis Patients
A clinical trial evaluating nailfold capillaroscopy in pediatric uveitis patients has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis [Phase 2]
Phase 2 trial update for izokibep assessing efficacy and safety in non-anterior uveitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Abatacept in Patients With Birdshot HLA A29 Uveitis [Phase 2]
Phase 2 clinical trial evaluating abatacept in patients with Birdshot uveitis (HLA-A29 positive). Completed.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study [Phase 4]
A Phase 4 proof-of-concept trial evaluating ixekizumab for refractory non-infectious uveitis across posterior, anterior, intermediate, and p…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uveitis [Phase 3]
Phase 3 clinical trial investigating efficacy, safety, and costs of methotrexate, adalimumab, or their combination in non-infectious non-ant…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial [Phase 3]
Phase 3 trial comparing ranibizumab to intravitreal anti-inflammatory therapy in uveitis-associated macular edema has completed with results…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF [Phase 2, Phase 3]
A multi-phase clinical trial evaluating Conbercept for refractory uveitic macular edema has been terminated after Phase 2/3.